A new clinical trial has shown that the Cefaly migraine treatment device is safe and effective for migraine prevention, according to manufacturer Cefaly Technology. Cefaly is an external trigeminal nerve stimulation device (e-TNS) that is magnetically connected to a self-adhesive electrode placed on the forehead. It sends micro-impulses through … [Read more...] about Trial: Cefaly wearable safe, effective in preventing migraines
Research
Study: Boston Sci’s Watchman cheaper than drugs long-term
A new study has found that use of the Boston Scientific (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device to treat atrial fibrillation costs less than existing and novel anticoagulant drugs over five years. The retrospective study pooled data from the randomized trials of the Marlborough, Mass.-based company’s Watchman device. The … [Read more...] about Study: Boston Sci’s Watchman cheaper than drugs long-term
CMS expands TAVR coverage
The Centers for Medicare and Medicaid Services have updated the criteria for hospitals and physicians to begin or continue providing transcatheter aortic valve replacement surgery. The decision gives hospitals and providers more flexibility to meet the CMS requirements for performing TAVR, the agency said Friday. The original National Coverage … [Read more...] about CMS expands TAVR coverage
Survey: Few adults know signs of heart failure
Only one in five adults can accurately recognize the signs and symptoms of heart failure, according to a new survey commissioned by Abbott (NYSE:ABT). The survey of more than 3,000 Americans revealed a significant gap in awareness of what heart failure is and an understanding of how the disease can be managed. More than six million Americans are … [Read more...] about Survey: Few adults know signs of heart failure
